Lv3
300 积分 2023-11-22 加入
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
1天前
待确认
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis
2天前
已完结
Lisaftoclax: First Approval
13天前
已完结
Patent landscape of inhibitors and PROTACs of the anti-apoptotic BCL-2 family proteins
14天前
已完结
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial
16天前
已完结
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
19天前
已完结
A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
22天前
已完结
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial
23天前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
23天前
已完结
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
23天前
已完结
皖公网安备34019202002308
